Literature DB >> 33693021

Current Challenges in the Management of Infective Endocarditis.

Guillermo Cuervo1,2, Francesc Escrihuela-Vidal1, Carlota Gudiol1,2,3, Jordi Carratalà1,2.   

Abstract

Infective endocarditis is a relatively rare, but deadly cause of sepsis, with an overall mortality ranging from 20 to 25% in most series. Although the classic clinical classification into syndromes of acute or subacute endocarditis have not completely lost their usefulness, current clinical forms have changed according to the profound epidemiological changes observed in developed countries. In this review, we aim to address the changing epidemiology of endocarditis, several recent advances in the understanding of the pathophysiology of endocarditis and endocarditis-triggered sepsis, new useful diagnostic tools as well as current concepts in the medical and surgical management of this disease. Given its complexity, the management of infective endocarditis requires the close collaboration of multidisciplinary endocarditis teams that must decide on the diagnostic approach; the appropriate initial treatment in the critical phase; the detection of patients needing surgery and the timing of this intervention; and finally the accurate selection of patients for out-of-hospital treatment, either at home hospitalization or with oral antibiotic treatment.
Copyright © 2021 Cuervo, Escrihuela-Vidal, Gudiol and Carratalà.

Entities:  

Keywords:  Enterococcus; Staphycoccus aureus; infective endocarditis; positron - emission tomography; transesophageal echocardiography - three-dimensional echocardiography; viridans group streptococci

Year:  2021        PMID: 33693021      PMCID: PMC7937698          DOI: 10.3389/fmed.2021.641243

Source DB:  PubMed          Journal:  Front Med (Lausanne)        ISSN: 2296-858X


  8 in total

1.  A Rare Case of Endocarditis and Mycotic Pseudoaneurysm of the Left Ventricle Caused by Escherichia coli Following Transcatheter Aortic Valve Replacement.

Authors:  Batel Nissan; Mutaz Karameh; Yonatan Oster; Rabea Asleh
Journal:  Cureus       Date:  2022-07-31

Review 2.  Pathogenesis, Diagnosis, Antimicrobial Therapy, and Management of Infective Endocarditis, and Its Complications.

Authors:  Saakshi P Kamde; Anil Anjankar
Journal:  Cureus       Date:  2022-09-15

3.  Infective endocarditis treated in a secondary hospital: epidemiological, clinical, microbiological characteristics and prognosis, with special reference to patients transferred to a third level hospital.

Authors:  A I Peláez Ballesta; E García Vázquez; J Gómez Gómez
Journal:  Rev Esp Quimioter       Date:  2021-11-30       Impact factor: 1.553

4.  A Patient's Six-Month Journey From Low Sodium to Blue Toes to Stroke: Non-infective Thrombotic Endocarditis Due to Non-small Cell Lung Cancer.

Authors:  Jocelyn McCullough; Joseph McCullough; Alan Kaell
Journal:  Cureus       Date:  2022-03-16

5.  Unusual Presentation of Infective Endocarditis Following a Prostatic Urethral Lift.

Authors:  Suchit Chidurala; Manikumar Bheemarasetti
Journal:  Cureus       Date:  2022-07-16

Review 6.  Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.

Authors:  Joop J P Kouijzer; Daniëlle J Noordermeer; Wouter J van Leeuwen; Nelianne J Verkaik; Kirby R Lattwein
Journal:  Front Cell Dev Biol       Date:  2022-10-03

7.  Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials.

Authors:  Moritz Mirna; Albert Topf; Lukas Schmutzler; Uta C Hoppe; Michael Lichtenauer
Journal:  Clin Res Cardiol       Date:  2021-11-09       Impact factor: 6.138

8.  Linezolid for infective endocarditis: A structured approach based on a national database experience.

Authors:  P Muñoz; S De la Villa; M Martínez-Sellés; M A Goenaga; K Reviejo-Jaka; F Arnáiz de Las Revillas; L García-Cuello; C Hidalgo-Tenorio; M A Rodríguez-Esteban; I Antorrena; L Castelo-Corral; E García-Vázquez; J De la Torre; E Bouza
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.